Skip to main content
. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797

Table 2.

Schedule of eligibility screening and clinical follow-up

Eligibility screening Days
1–180
Every 6 months through year 5 Every 12 months through year 5 Every 12 months through years 5–7
Tests and observations History and physical X Registration X X
Weight, height X
Pulse, blood pressure X
Randomisation X
Imaging studies β Contralateral MMG X
Ipsilateral breast imaging Xγ X
(AS only)
X
(GCC only)
Bilateral MMG Xγ X
Therapeutic procedures Surgery X
(GCC only)
Radiation X
(GCC only)
Discussion regarding endocrine therapy. Initiation if patient opts for treatment X

AS, active surveillance; GCC, guideline concordant care; MMG, mammogram.